Sangamo Biosciences Inc
Sangamo Therapeutics, based in Richmond, California, is at the forefront of genomic medicine, leveraging its proprietary zinc finger technology to develop innovative genomic cures for severe diseases that conventional medicine can only manage symptomatically. The company focuses on therapeutic applications across neurology and oncology, with a robust pipeline that includes treatments for conditions like Fabry disease and Hemophilia A.
Committed to transforming groundbreaking scientific advancements into tangible healthcare solutions, Sangamo Therapeutics maintains a strong emphasis on research and development collaborations with leading pharmaceutical partners. Their dedication is evident in their extensive clinical trials and ongoing efforts to refine gene therapies, aiming to improve patient outcomes and extend survival for those affected by debilitating diseases.
Generated from the website